Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Failure | 25 | 2023 | 10896 | 1.660 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 11 | 2023 | 1516 | 1.660 |
Why?
|
Renal Insufficiency, Chronic | 12 | 2023 | 2200 | 1.510 |
Why?
|
Angiotensin Receptor Antagonists | 8 | 2023 | 923 | 1.500 |
Why?
|
Acidosis | 2 | 2022 | 271 | 1.330 |
Why?
|
Glomerular Filtration Rate | 6 | 2021 | 2167 | 1.100 |
Why?
|
Hemodynamics | 5 | 2020 | 4197 | 0.840 |
Why?
|
Kidney | 9 | 2023 | 7185 | 0.820 |
Why?
|
Ventricular Function, Right | 3 | 2019 | 589 | 0.740 |
Why?
|
Enteritis | 1 | 2021 | 165 | 0.730 |
Why?
|
Acute Generalized Exanthematous Pustulosis | 1 | 2019 | 13 | 0.720 |
Why?
|
Sodium Bicarbonate | 1 | 2019 | 63 | 0.700 |
Why?
|
Diuretics | 3 | 2021 | 591 | 0.700 |
Why?
|
Mupirocin | 1 | 2019 | 56 | 0.700 |
Why?
|
Cardiovascular System | 3 | 2023 | 828 | 0.690 |
Why?
|
Acute Kidney Injury | 7 | 2021 | 1968 | 0.670 |
Why?
|
Ventricular Dysfunction, Left | 4 | 2023 | 2074 | 0.670 |
Why?
|
Stroke Volume | 10 | 2023 | 5002 | 0.670 |
Why?
|
Hospital Mortality | 17 | 2021 | 5316 | 0.660 |
Why?
|
Diabetic Ketoacidosis | 1 | 2022 | 247 | 0.650 |
Why?
|
Ophthalmic Solutions | 1 | 2019 | 316 | 0.640 |
Why?
|
Histiocytic Necrotizing Lymphadenitis | 1 | 2018 | 23 | 0.640 |
Why?
|
Dexmedetomidine | 1 | 2022 | 315 | 0.630 |
Why?
|
CADASIL | 1 | 2018 | 84 | 0.610 |
Why?
|
Ciprofloxacin | 1 | 2019 | 314 | 0.610 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2022 | 632 | 0.610 |
Why?
|
Heart Ventricles | 3 | 2018 | 3817 | 0.570 |
Why?
|
Hypothermia | 1 | 2018 | 189 | 0.550 |
Why?
|
Heart Block | 1 | 2018 | 410 | 0.550 |
Why?
|
Exanthema | 1 | 2021 | 501 | 0.540 |
Why?
|
Diabetic Nephropathies | 1 | 2023 | 984 | 0.540 |
Why?
|
Angioedema | 3 | 2021 | 187 | 0.530 |
Why?
|
Cocaine-Related Disorders | 1 | 2018 | 460 | 0.510 |
Why?
|
Diabetes Mellitus | 4 | 2022 | 5752 | 0.490 |
Why?
|
Mitral Valve | 2 | 2020 | 1491 | 0.460 |
Why?
|
Glucocorticoids | 2 | 2019 | 2107 | 0.440 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2018 | 1240 | 0.440 |
Why?
|
Renal Insufficiency | 1 | 2018 | 805 | 0.430 |
Why?
|
Chest Pain | 1 | 2018 | 1114 | 0.400 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2021 | 11729 | 0.380 |
Why?
|
Humans | 93 | 2023 | 743811 | 0.370 |
Why?
|
Randomized Controlled Trials as Topic | 8 | 2023 | 9944 | 0.360 |
Why?
|
Pandemics | 8 | 2021 | 8385 | 0.330 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2021 | 2104 | 0.330 |
Why?
|
Echocardiography | 4 | 2021 | 5096 | 0.330 |
Why?
|
Anterior Wall Myocardial Infarction | 2 | 2018 | 44 | 0.320 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2019 | 1537 | 0.310 |
Why?
|
Coronavirus Infections | 6 | 2020 | 3134 | 0.310 |
Why?
|
Pneumonia, Viral | 6 | 2020 | 3241 | 0.310 |
Why?
|
Retrospective Studies | 36 | 2023 | 77410 | 0.310 |
Why?
|
Critical Illness | 2 | 2021 | 2670 | 0.300 |
Why?
|
Fluid Therapy | 2 | 2022 | 593 | 0.300 |
Why?
|
Resuscitation | 2 | 2022 | 658 | 0.290 |
Why?
|
Patient Readmission | 5 | 2021 | 3117 | 0.280 |
Why?
|
Pulmonary Embolism | 3 | 2023 | 2375 | 0.280 |
Why?
|
Skin | 1 | 2019 | 4372 | 0.270 |
Why?
|
Hospitalization | 15 | 2021 | 10259 | 0.250 |
Why?
|
Pulmonary Infarction | 1 | 2023 | 9 | 0.240 |
Why?
|
Cardiac Surgical Procedures | 1 | 2019 | 3537 | 0.230 |
Why?
|
Mineralocorticoids | 1 | 2023 | 38 | 0.220 |
Why?
|
Aged | 34 | 2023 | 163178 | 0.220 |
Why?
|
Female | 42 | 2023 | 380020 | 0.210 |
Why?
|
Diuresis | 1 | 2022 | 116 | 0.210 |
Why?
|
Receptors, Mineralocorticoid | 1 | 2023 | 164 | 0.210 |
Why?
|
Dihydropyridines | 1 | 2021 | 67 | 0.200 |
Why?
|
Hypertension | 3 | 2022 | 8480 | 0.200 |
Why?
|
Renal Dialysis | 2 | 2021 | 1783 | 0.200 |
Why?
|
Calcinosis | 2 | 2020 | 1495 | 0.200 |
Why?
|
Electrolytes | 1 | 2022 | 282 | 0.190 |
Why?
|
Osmolar Concentration | 1 | 2022 | 683 | 0.190 |
Why?
|
Lisinopril | 1 | 2021 | 54 | 0.190 |
Why?
|
Male | 39 | 2023 | 349776 | 0.190 |
Why?
|
Hemofiltration | 1 | 2020 | 57 | 0.190 |
Why?
|
Middle Aged | 28 | 2023 | 213241 | 0.180 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2021 | 114 | 0.180 |
Why?
|
Emollients | 1 | 2019 | 34 | 0.180 |
Why?
|
Hypoglycemic Agents | 3 | 2021 | 2877 | 0.180 |
Why?
|
Conjunctivitis, Bacterial | 1 | 2019 | 24 | 0.180 |
Why?
|
Atrial Function, Right | 1 | 2019 | 33 | 0.180 |
Why?
|
Stroke | 2 | 2021 | 9975 | 0.180 |
Why?
|
Echocardiography, Stress | 1 | 2020 | 131 | 0.170 |
Why?
|
Carcinoid Heart Disease | 1 | 2019 | 10 | 0.170 |
Why?
|
Ascites | 1 | 2021 | 344 | 0.170 |
Why?
|
Cardiomyopathy, Alcoholic | 1 | 2018 | 6 | 0.170 |
Why?
|
Polycythemia Vera | 1 | 2020 | 164 | 0.170 |
Why?
|
Time Factors | 12 | 2021 | 40038 | 0.170 |
Why?
|
Tranexamic Acid | 1 | 2021 | 146 | 0.170 |
Why?
|
Venous Thromboembolism | 2 | 2021 | 1670 | 0.170 |
Why?
|
Environmental Health | 1 | 2021 | 278 | 0.160 |
Why?
|
Acute Coronary Syndrome | 2 | 2023 | 2337 | 0.160 |
Why?
|
Relief Work | 1 | 2020 | 137 | 0.160 |
Why?
|
Thrombosis | 3 | 2023 | 2968 | 0.160 |
Why?
|
Veterans | 2 | 2022 | 2519 | 0.160 |
Why?
|
Risk Factors | 19 | 2023 | 72252 | 0.160 |
Why?
|
Antifibrinolytic Agents | 1 | 2021 | 254 | 0.160 |
Why?
|
Hyperuricemia | 1 | 2021 | 210 | 0.160 |
Why?
|
Hospitals, Urban | 1 | 2020 | 499 | 0.160 |
Why?
|
Medically Underserved Area | 1 | 2020 | 252 | 0.160 |
Why?
|
Catheters, Indwelling | 1 | 2020 | 427 | 0.160 |
Why?
|
Eligibility Determination | 1 | 2021 | 404 | 0.150 |
Why?
|
Administration, Topical | 1 | 2019 | 689 | 0.150 |
Why?
|
Mitral Valve Stenosis | 1 | 2020 | 376 | 0.150 |
Why?
|
Coronavirus | 1 | 2020 | 158 | 0.150 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2022 | 339 | 0.150 |
Why?
|
Hemorrhage | 2 | 2020 | 3458 | 0.150 |
Why?
|
Hyperostosis, Diffuse Idiopathic Skeletal | 1 | 2017 | 23 | 0.150 |
Why?
|
Foot | 1 | 2021 | 527 | 0.150 |
Why?
|
Drug Substitution | 1 | 2019 | 281 | 0.150 |
Why?
|
Ascorbic Acid | 1 | 2020 | 650 | 0.140 |
Why?
|
Peripartum Period | 1 | 2018 | 133 | 0.140 |
Why?
|
Biopsy | 2 | 2019 | 6750 | 0.140 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2021 | 289 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 17439 | 0.140 |
Why?
|
Benzodiazepines | 1 | 2022 | 1101 | 0.140 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2018 | 124 | 0.140 |
Why?
|
Endocarditis | 1 | 2020 | 349 | 0.140 |
Why?
|
Cardiovascular Diseases | 4 | 2023 | 15142 | 0.140 |
Why?
|
Philadelphia | 3 | 2021 | 267 | 0.140 |
Why?
|
Treatment Outcome | 8 | 2023 | 63042 | 0.140 |
Why?
|
Prognosis | 7 | 2023 | 29052 | 0.140 |
Why?
|
Echocardiography, Doppler | 1 | 2020 | 935 | 0.140 |
Why?
|
Intubation, Intratracheal | 2 | 2021 | 1365 | 0.140 |
Why?
|
Comorbidity | 8 | 2021 | 10380 | 0.130 |
Why?
|
Albuminuria | 1 | 2019 | 681 | 0.130 |
Why?
|
Aged, 80 and over | 11 | 2023 | 57744 | 0.130 |
Why?
|
Hand | 1 | 2021 | 884 | 0.130 |
Why?
|
Thromboembolism | 2 | 2018 | 987 | 0.130 |
Why?
|
Withholding Treatment | 1 | 2019 | 599 | 0.130 |
Why?
|
Exercise Tolerance | 1 | 2020 | 768 | 0.130 |
Why?
|
Respiratory Insufficiency | 1 | 2023 | 1199 | 0.130 |
Why?
|
Abdominal Pain | 1 | 2021 | 1064 | 0.120 |
Why?
|
Follow-Up Studies | 7 | 2023 | 39001 | 0.120 |
Why?
|
Disease Progression | 5 | 2023 | 13273 | 0.120 |
Why?
|
Diarrhea | 1 | 2021 | 1348 | 0.120 |
Why?
|
Anemia | 1 | 2023 | 1502 | 0.120 |
Why?
|
Antihypertensive Agents | 2 | 2023 | 2047 | 0.120 |
Why?
|
Breast Neoplasms | 2 | 2021 | 20827 | 0.120 |
Why?
|
Acute Disease | 5 | 2023 | 7150 | 0.120 |
Why?
|
Cohort Studies | 5 | 2023 | 40545 | 0.120 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2019 | 581 | 0.120 |
Why?
|
American Heart Association | 3 | 2023 | 1057 | 0.120 |
Why?
|
Ventricular Function, Left | 3 | 2022 | 3660 | 0.110 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12954 | 0.110 |
Why?
|
Dyslipidemias | 1 | 2021 | 851 | 0.110 |
Why?
|
Thrombolytic Therapy | 2 | 2023 | 2162 | 0.110 |
Why?
|
Prednisone | 1 | 2018 | 1574 | 0.110 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2020 | 1131 | 0.110 |
Why?
|
Intensive Care Units | 3 | 2022 | 3679 | 0.110 |
Why?
|
Exercise Test | 1 | 2020 | 2074 | 0.110 |
Why?
|
Lymphocytes | 1 | 2020 | 2615 | 0.110 |
Why?
|
Risk Assessment | 5 | 2023 | 23327 | 0.100 |
Why?
|
Bacterial Infections | 1 | 2020 | 1400 | 0.100 |
Why?
|
Anti-Bacterial Agents | 2 | 2020 | 7172 | 0.100 |
Why?
|
Vitamins | 1 | 2020 | 1622 | 0.100 |
Why?
|
Anticoagulants | 3 | 2023 | 4599 | 0.100 |
Why?
|
Hospital Costs | 1 | 2018 | 985 | 0.100 |
Why?
|
Deglutition Disorders | 1 | 2017 | 606 | 0.100 |
Why?
|
Pulmonary Artery | 1 | 2019 | 1911 | 0.100 |
Why?
|
Patient Admission | 1 | 2018 | 1380 | 0.100 |
Why?
|
Length of Stay | 2 | 2022 | 6311 | 0.090 |
Why?
|
Heart Arrest | 1 | 2021 | 1470 | 0.090 |
Why?
|
United States | 14 | 2023 | 69859 | 0.090 |
Why?
|
Aortic Valve | 1 | 2020 | 1920 | 0.090 |
Why?
|
Obesity, Morbid | 1 | 2021 | 1213 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2022 | 2217 | 0.090 |
Why?
|
Adult | 14 | 2023 | 213889 | 0.090 |
Why?
|
Kidney Diseases | 1 | 2021 | 2146 | 0.090 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2210 | 0.090 |
Why?
|
Inpatients | 1 | 2021 | 2515 | 0.090 |
Why?
|
Blood Platelets | 1 | 2020 | 2509 | 0.090 |
Why?
|
Troponin | 2 | 2023 | 524 | 0.090 |
Why?
|
Insulin | 2 | 2021 | 6584 | 0.080 |
Why?
|
Patient Selection | 1 | 2021 | 4210 | 0.080 |
Why?
|
Diagnostic Imaging | 2 | 2023 | 3503 | 0.080 |
Why?
|
Fibrin Fibrinogen Degradation Products | 2 | 2021 | 426 | 0.080 |
Why?
|
Urban Population | 3 | 2021 | 2021 | 0.080 |
Why?
|
Calcium Channel Blockers | 2 | 2021 | 692 | 0.080 |
Why?
|
Pregnancy Complications | 1 | 2022 | 2861 | 0.080 |
Why?
|
Aortic Valve Stenosis | 1 | 2020 | 1955 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2459 | 0.080 |
Why?
|
Hypertension, Pulmonary | 1 | 2019 | 1534 | 0.080 |
Why?
|
Neutrophils | 1 | 2020 | 3718 | 0.080 |
Why?
|
Health Care Costs | 1 | 2020 | 3207 | 0.070 |
Why?
|
Renin-Angiotensin System | 2 | 2023 | 758 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2022 | 4251 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3047 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 3 | 2021 | 1789 | 0.070 |
Why?
|
Epilepsy | 1 | 2022 | 3284 | 0.070 |
Why?
|
Hydroxychloroquine | 2 | 2020 | 412 | 0.070 |
Why?
|
Respiration, Artificial | 3 | 2023 | 2568 | 0.070 |
Why?
|
Aftercare | 2 | 2023 | 870 | 0.070 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2020 | 3338 | 0.070 |
Why?
|
Cardiomyopathies | 1 | 2018 | 1911 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 3255 | 0.070 |
Why?
|
Kidney Transplantation | 1 | 2020 | 4251 | 0.060 |
Why?
|
Sex Distribution | 2 | 2020 | 2298 | 0.060 |
Why?
|
Electrocardiography | 1 | 2018 | 6441 | 0.060 |
Why?
|
Age Distribution | 2 | 2020 | 2899 | 0.060 |
Why?
|
Atherosclerosis | 1 | 2019 | 3445 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2021 | 5033 | 0.060 |
Why?
|
Algorithms | 1 | 2023 | 13869 | 0.050 |
Why?
|
Severity of Illness Index | 4 | 2020 | 15526 | 0.050 |
Why?
|
Asthma | 1 | 2021 | 6010 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2023 | 11708 | 0.050 |
Why?
|
Logistic Models | 3 | 2021 | 13404 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2021 | 6485 | 0.050 |
Why?
|
Liver Cirrhosis | 2 | 2021 | 1859 | 0.050 |
Why?
|
Melena | 1 | 2020 | 34 | 0.050 |
Why?
|
Survival Rate | 3 | 2020 | 12786 | 0.050 |
Why?
|
Prospective Studies | 2 | 2022 | 53250 | 0.050 |
Why?
|
Incidence | 4 | 2020 | 20948 | 0.050 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15067 | 0.050 |
Why?
|
Hemoglobin A | 1 | 2020 | 87 | 0.050 |
Why?
|
Off-Label Use | 1 | 2021 | 169 | 0.050 |
Why?
|
Ultrafiltration | 1 | 2020 | 57 | 0.050 |
Why?
|
Neprilysin | 1 | 2022 | 439 | 0.040 |
Why?
|
Pennsylvania | 1 | 2021 | 613 | 0.040 |
Why?
|
Patient Discharge | 2 | 2023 | 3317 | 0.040 |
Why?
|
Blood Cell Count | 1 | 2020 | 403 | 0.040 |
Why?
|
Prevalence | 3 | 2020 | 15211 | 0.040 |
Why?
|
Mortality | 2 | 2021 | 2862 | 0.040 |
Why?
|
Adolescent | 3 | 2022 | 85729 | 0.040 |
Why?
|
Methylprednisolone | 1 | 2020 | 387 | 0.040 |
Why?
|
Bicycling | 1 | 2020 | 176 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 20121 | 0.040 |
Why?
|
Chlorides | 1 | 2021 | 667 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2021 | 19894 | 0.040 |
Why?
|
Young Adult | 3 | 2020 | 56392 | 0.040 |
Why?
|
Cities | 1 | 2020 | 512 | 0.040 |
Why?
|
Antiviral Agents | 2 | 2020 | 2984 | 0.040 |
Why?
|
Hyperkalemia | 1 | 2020 | 218 | 0.040 |
Why?
|
Aldosterone | 1 | 2023 | 877 | 0.040 |
Why?
|
Glucosides | 1 | 2021 | 451 | 0.040 |
Why?
|
Hemoglobins | 1 | 2023 | 1531 | 0.040 |
Why?
|
Ferritins | 1 | 2020 | 590 | 0.040 |
Why?
|
Creatinine | 1 | 2023 | 1918 | 0.040 |
Why?
|
Demography | 1 | 2022 | 1653 | 0.040 |
Why?
|
Vasoconstrictor Agents | 1 | 2021 | 642 | 0.040 |
Why?
|
Multivariate Analysis | 2 | 2021 | 12243 | 0.040 |
Why?
|
Blood Transfusion | 1 | 2023 | 1301 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2019 | 15281 | 0.040 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 25032 | 0.040 |
Why?
|
Respiratory Mechanics | 1 | 2021 | 686 | 0.040 |
Why?
|
Awareness | 1 | 2020 | 639 | 0.030 |
Why?
|
Palliative Care | 2 | 2022 | 3490 | 0.030 |
Why?
|
Sodium | 1 | 2021 | 1622 | 0.030 |
Why?
|
Uric Acid | 1 | 2021 | 765 | 0.030 |
Why?
|
Benzhydryl Compounds | 1 | 2021 | 844 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1851 | 0.030 |
Why?
|
Vulnerable Populations | 1 | 2021 | 685 | 0.030 |
Why?
|
Steroids | 1 | 2020 | 930 | 0.030 |
Why?
|
HIV Infections | 1 | 2020 | 16715 | 0.030 |
Why?
|
Administration, Oral | 1 | 2021 | 3912 | 0.030 |
Why?
|
Bacteremia | 1 | 2020 | 963 | 0.030 |
Why?
|
Antimalarials | 1 | 2020 | 904 | 0.030 |
Why?
|
Databases, Factual | 2 | 2018 | 7729 | 0.030 |
Why?
|
Morbidity | 1 | 2019 | 1768 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2020 | 21733 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2022 | 1910 | 0.030 |
Why?
|
Staphylococcus aureus | 1 | 2020 | 1453 | 0.030 |
Why?
|
Dyspnea | 1 | 2020 | 1303 | 0.030 |
Why?
|
Propensity Score | 1 | 2018 | 1781 | 0.030 |
Why?
|
Coronary Angiography | 1 | 2023 | 4576 | 0.030 |
Why?
|
Neoplasms | 1 | 2019 | 21675 | 0.020 |
Why?
|
Cervical Vertebrae | 1 | 2017 | 976 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5078 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6487 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2020 | 2583 | 0.020 |
Why?
|
Heart | 1 | 2023 | 4460 | 0.020 |
Why?
|
Contrast Media | 1 | 2022 | 5301 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2022 | 3530 | 0.020 |
Why?
|
Fibrinolytic Agents | 1 | 2018 | 2159 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3089 | 0.020 |
Why?
|
Calcium | 1 | 2021 | 5755 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9848 | 0.020 |
Why?
|
Risk | 1 | 2020 | 9677 | 0.020 |
Why?
|
Kidney Failure, Chronic | 1 | 2020 | 2534 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10251 | 0.020 |
Why?
|
Blood Pressure | 1 | 2022 | 8551 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8637 | 0.020 |
Why?
|
Blood Glucose | 1 | 2020 | 6259 | 0.020 |
Why?
|
Heart Diseases | 1 | 2018 | 2789 | 0.020 |
Why?
|
Age Factors | 1 | 2021 | 18355 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 7908 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4467 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 2018 | 4254 | 0.010 |
Why?
|
Smoking | 1 | 2018 | 8984 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10629 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 29140 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 6773 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2019 | 11059 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2022 | 35409 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2019 | 13112 | 0.010 |
Why?
|